Filing Flows › Iridex (IRIX) › Q1 2026 › vs Q4 2025
Iridex (IRIX) Q1 2026 vs Q4 2025 (quarter over quarter)
Iridex's revenue fell $2.9M (-20%) from $14.7M in Q4 2025 to $11.8M in Q1 2026. The biggest changes: Retina −$3.1M (-34%); Product and Service Other +$326K (+16%); Cyclo G Six −$188K (-5%).
Iridex, Q1 2026: revenue $11.8M (-0.8% year over year), operating margin -2.7%, net loss $524K, operating cash flow −$1.3M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Retina | $5.8M | $8.9M | −$3.1M | -34% |
| Cyclo G Six | $3.6M | $3.8M | −$188K | -5% |
| Product and Service Other | $2.3M | $2.0M | $326K | +16% |
| Revenue | $11.8M | $14.7M | −$2.9M | -20% |
| Net loss | $524K | $184K | $340K | +185% |
| Costs & expenses | $12.3M | $14.9M | −$2.6M | -17% |
| Operating costs | $12.1M | $14.7M | −$2.6M | -18% |
| Interest & other, net | $142K | $149K | −$7K | -5% |
| Income tax | $58K | $20K | $38K | +190% |
| Cost of revenue | $7.1M | $9.2M | −$2.2M | -24% |
| Research & development | $905K | $949K | −$44K | -5% |
| Sales & marketing | $2.5M | $2.8M | −$214K | -8% |
| General & admin | $1.6M | $1.8M | −$169K | -9% |
| Operating cash sources | $1.6M | −$225K | $1.9M | — |
| Depreciation & amortization | $100K | $151K | −$51K | -34% |
| Share-based compensation | $211K | $213K | −$2K | -0.9% |
| Cash used in operations | $1.3M | −$589K | $1.9M | — |
| Net loss absorbed | $524K | $184K | $340K | +185% |
| Working capital & other | $1.1M | −$409K | $1.5M | — |
Questions
How much did Iridex's revenue grow quarter over quarter in Q1 2026?
Iridex's revenue fell $2.9M (-20%) from $14.7M in Q4 2025 to $11.8M in Q1 2026.
What drove Iridex's revenue change in Q1 2026?
Retina −$3.1M (-34%); Product and Service Other +$326K (+16%); Cyclo G Six −$188K (-5%).